Latest Artia Global Partners LP Stock Portfolio
$517Million– No. of Holdings #42
Artia Global Partners LP Performance:
2024 Q2: -0.07%YTD: 18.08%2023: 1.83%
Performance for 2024 Q2 is -0.07%, and YTD is 18.08%, and 2023 is 1.83%.
About Artia Global Partners LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Artia Global Partners LP reported an equity portfolio of $517.3 Millions as of 30 Jun, 2024.
The top stock holdings of Artia Global Partners LP are , LLY, MRK. The fund has invested 19.1% of it's portfolio in NOVO-NORDISK A S and 16.2% of portfolio in ELI LILLY & CO.
The fund managers got completely rid off ABBVIE INC (ABBV), CYTOKINETICS INC (CYTK) and ALPINE IMMUNE SCIENCES INC (ALPN) stocks. They significantly reduced their stock positions in DISC MEDICINE INC, INSMED INC (INSM) and PLIANT THERAPEUTICS INC (PLRX). Artia Global Partners LP opened new stock positions in ALNYLAM PHARMACEUTICALS INC (ALNY), IONIS PHARMACEUTICALS INC (IONS) and CELLDEX THERAPEUTICS INC NEW (CLDX). The fund showed a lot of confidence in some stocks as they added substantially to SOLENO THERAPEUTICS INC (SLNO), EYEPOINT PHARMACEUTICALS INC (EYPT) and LARIMAR THERAPEUTICS INC (LRMR).
The top stock holdings of Artia Global Partners LP are , LLY, MRK. The fund has invested 19.1% of it's portfolio in NOVO-NORDISK A S and 16.2% of portfolio in ELI LILLY & CO.
The fund managers got completely rid off ABBVIE INC (ABBV), CYTOKINETICS INC (CYTK) and ALPINE IMMUNE SCIENCES INC (ALPN) stocks. They significantly reduced their stock positions in DISC MEDICINE INC, INSMED INC (INSM) and PLIANT THERAPEUTICS INC (PLRX). Artia Global Partners LP opened new stock positions in ALNYLAM PHARMACEUTICALS INC (ALNY), IONIS PHARMACEUTICALS INC (IONS) and CELLDEX THERAPEUTICS INC NEW (CLDX). The fund showed a lot of confidence in some stocks as they added substantially to SOLENO THERAPEUTICS INC (SLNO), EYEPOINT PHARMACEUTICALS INC (EYPT) and LARIMAR THERAPEUTICS INC (LRMR).
Artia Global Partners LP Equity Portfolio Value
Last Reported on: 14 Aug, 2024
Artia Global Partners LP Annual Return Estimates Vs S&P 500
Our best estimate is that Artia Global Partners LP made a return of -0.07% in the last quarter. In trailing 12 months, it's portfolio return was 23.94%.
New Buys
| Ticker | $ Bought |
|---|---|
| alnylam pharmaceuticals inc | 8,505,000 |
| ionis pharmaceuticals inc | 2,977,750 |
| celldex therapeutics inc new | 2,786,850 |
| syndax pharmaceuticals inc | 990,839 |
| keros therapeutics inc | 914,000 |
| corbus pharmaceuticals hldgs | 905,000 |
| sarepta therapeutics inc | 410,800 |
New stocks bought by Artia Global Partners LP
Additions
| Ticker | % Inc. |
|---|---|
| soleno therapeutics inc | 130 |
| eyepoint pharmaceuticals inc | 97.09 |
| larimar therapeutics inc | 55.51 |
| kura oncology inc | 44.84 |
| merck & co inc | 16.69 |
| viking therapeutics inc | 4.47 |
| ideaya biosciences inc | 3.62 |
| intra-cellular therapies inc | 3.06 |
Additions to existing portfolio by Artia Global Partners LP
Reductions
| Ticker | % Reduced |
|---|---|
| disc medicine inc | -84.56 |
| argenx se | -55.79 |
| insmed inc | -54.81 |
| ascendis pharma a/s | -53.19 |
| pliant therapeutics inc | -50.00 |
| vertex pharmaceuticals inc | -34.6 |
| ocular therapeutix inc | -31.00 |
| apogee therapeutics inc | -5.18 |
Artia Global Partners LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| rapt therapeutics inc | -1,233,030 |
| gritstone bio inc | -244,587 |
| abbvie inc | -16,538,500 |
| cytokinetics inc | -6,276,600 |
| poseida therapeutics inc | -274,346 |
| macrogenics inc | -942,183 |
| alpine immune sciences inc | -2,049,940 |
| janux therapeutics inc | -1,805,280 |
Artia Global Partners LP got rid off the above stocks
Sector Distribution
Artia Global Partners LP has about 67.9% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 67.9 |
| Others | 32.1 |
Market Cap. Distribution
Artia Global Partners LP has about 43% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MEGA-CAP | 35.6 |
| UNALLOCATED | 32.7 |
| MID-CAP | 20.7 |
| LARGE-CAP | 7.4 |
| SMALL-CAP | 3.6 |
Stocks belong to which Index?
About 59.8% of the stocks held by Artia Global Partners LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 40.2 |
| S&P 500 | 38.2 |
| RUSSELL 2000 | 21.6 |
Artia Global Partners LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Artia Global Partners LP
Artia Global Partners LP has 42 stocks in it's portfolio. About 62.2% of the portfolio is in top 10 stocks. VKTX proved to be the most loss making stock for the portfolio. LLY was the most profitable stock for Artia Global Partners LP last quarter.
Last Reported on: 14 Aug, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABBV | abbvie inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALNY | alnylam pharmaceuticals inc | 1.64 | 35,000 | 8,505,000 | new | |||
| ALPN | alpine immune sciences inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ANNX | annexon inc | 0.14 | 147,485 | 722,677 | unchanged | 0.00 | ||
| ARVN | arvinas inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AXSM | axsome therapeutics inc | 1.37 | 87,848 | 7,071,760 | unchanged | 0.00 | ||
| BMEA | biomea fusion inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CLDX | celldex therapeutics inc new | 0.54 | 75,300 | 2,786,850 | new | |||
| CRBP | corbus pharmaceuticals hldgs | 0.17 | 20,000 | 905,000 | new | |||
| CRL | charles riv labs intl inc | 0.28 | 6,905 | 1,426,440 | unchanged | 0.00 | ||
| CRNX | crinetics pharmaceuticals in | 0.74 | 85,765 | 3,841,410 | unchanged | 0.00 | ||
| CYTK | cytokinetics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| DYN | dyne therapeutics inc | 0.81 | 119,488 | 4,216,730 | unchanged | 0.00 | ||
| EYPT | eyepoint pharmaceuticals inc | 0.17 | 101,500 | 883,050 | added | 97.09 | ||
| GRTS | gritstone bio inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| IDYA | ideaya biosciences inc | 0.37 | 54,392 | 1,909,700 | added | 3.62 | ||
| IMVT | immunovant inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| INSM | insmed inc | 0.69 | 53,436 | 3,580,210 | reduced | -54.81 | ||
| IONS | ionis pharmaceuticals inc | 0.58 | 62,479 | 2,977,750 | new | |||
| ITCI | intra-cellular therapies inc | 2.87 | 216,519 | 14,829,400 | added | 3.06 | ||